Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
Background: Guidelines recommend combined therapy of glucocorticoid and cyclophosphamide (CYC) for patients with idiopathic membranous nephropathy (IMN), while it is associated with severe adverse effects. We conducted a retrospective study to evaluate the effectiveness and safety of glucocorticoid...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis Group
2019-01-01
|
| Серии: | Renal Failure |
| Предметы: | |
| Online-ссылка: | http://dx.doi.org/10.1080/0886022X.2019.1637758 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|